The role of genetic diversity in cancer

Por Merlo, Lauren M.F., Maley, Carlo C.
Publicado em 2010

IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity

Por Merlo, Lauren M.F., Mandik-Nayak, Laura
Publicado no Clin Med Insights Pathol (2016)

An empirical test of the concomitantly variable codon hypothesis

Por Merlo, Lauren M. F., Lunzer, Mark, Dean, Antony M.
Publicado em 2007

Cancer in Light of Experimental Evolution

Por Sprouffske, Kathleen, Merlo, Lauren M.F., Gerrish, Philip J., Maley, Carlo C., Sniegowski, Paul D.
Publicado em 2012

IDO2 in Immunomodulation and Autoimmune Disease

Por Prendergast, George C., Metz, Richard, Muller, Alexander J., Merlo, Lauren M. F., Mandik-Nayak, Laura
Publicado no Front Immunol (2014)

Development and Characterization of an Organotypic Model of Barrett’s Esophagus

Por Kosoff, Rachelle E., Gardiner, Kristin L., Merlo, Lauren M.F., Pavlov, Kirill, Rustgi, Anil K., Maley, Carlo C.
Publicado em 2012

IDO2 modulates T cell-dependent autoimmune responses through a B cell-intrinsic mechanism

Por Merlo, Lauren M.F., DuHadaway, James B., Grabler, Samantha, Prendergast, George C., Muller, Alexander J., Mandik-Nayak, Laura
Publicado no J Immunol (2016)

IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis()

Por Merlo, Lauren M.F., Pigott, Elizabeth, DuHadaway, James B., Grabler, Samantha, Metz, Richard, Prendergast, George C., Mandik-Nayak, Laura
Publicado em 2014

A comprehensive survey of clonal diversity measures in Barrett’s esophagus as biomarkers of progression to esophageal adenocarcinoma

Por Merlo, Lauren M.F., Shah, Najaf A., Li, Xiaohong, Blount, Patricia L., Vaughan, Thomas L., Reid, Brian J., Maley, Carlo C.
Publicado em 2010

Therapeutic Antibody Targeting of Indoleamine-2,3-Dioxygenase (IDO2) Inhibits Autoimmune Arthritis

Por Merlo, Lauren M.F., Grabler, Samantha, DuHadaway, James B., Pigott, Elizabeth, Manley, Kaylend, Prendergast, George C., Laury-Kleintop, Lisa D., Mandik-Nayak, Laura
Publicado no Clin Immunol (2017)

Application of simultaneous selective pressures slows adaptation

Por Merlo, Lauren M. F., Sprouffske, Kathleen, Howard, Taylor C., Gardiner, Kristin L., Caulin, Aleah F., Blum, Steven M., Evans, Perry, Bedalov, Antonio, Sniegowski, Paul D., Maley, Carlo C.
Publicado no Evol Appl (2020)

Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses

Por Merlo, Lauren M. F., DuHadaway, James B., Montgomery, James D., Peng, Wei-Dan, Murray, Peter J., Prendergast, George C., Caton, Andrew J., Muller, Alexander J., Mandik-Nayak, Laura
Publicado no Front Immunol (2020)

IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation

Por Metz, Richard, Smith, Courtney, DuHadaway, James B., Chandler, Phillip, Baban, Babak, Merlo, Lauren M. F., Pigott, Elizabeth, Keough, Martin P., Rust, Sonja, Mellor, Andrew L., Mandik-Nayak, Laura, Muller, Alexander J., Prendergast, George C.
Publicado no Int Immunol (2014)

Corrigendum: IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation

Por Metz, Richard, Smith, Courtney, DuHadaway, James B, Chandler, Phillip, Baban, Babak, Merlo, Lauren M F, Pigott, Elizabeth, Keough, Martin P, Rust, Sonja, Mellor, Andrew L, Mandik-Nayak, Laura, Muller, Alexander J, Prendergast, George C
Publicado no Int Immunol (2019)

Peptide vaccination directed against IDO1-expressing immune cells elicits CD8(+) and CD4(+) T-cell-mediated antitumor immunity and enhanced anti-PD1 responses

Por Dey, Souvik, Sutanto-Ward, Erika, Kopp, Katharina L, DuHadaway, James, Mondal, Arpita, Ghaban, Dema, Lecoq, Inés, Zocca, Mai-Britt, Merlo, Lauren M F, Mandik-Nayak, Laura, Andersen, Mads Hald, Pedersen, Ayako Wakatsuki, Muller, Alexander J
Publicado no J Immunother Cancer (2020)